Amanote Research
Register
Sign In
GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2019-051
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 5, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
CAR T-Cell Approvals: Multiple Myeloma Likely Next Up
The Journal of Community and Supportive Oncology
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Next Frontiers in CAR T-Cell Therapy
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research
Cancer Research
Oncology
Photothermal Therapy: Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells (Adv. Mater. 23/2019)
Advanced Materials
Mechanics of Materials
Materials Science
Nanotechnology
Mechanical Engineering
Nanoscience
CAR T Cell Immunotherapy for Multiple Myeloma. A Review of Current Data and Potential Clinical Applications
American Journal of Hematology
Hematology
CAR T-Cell Therapy for Solid Tumors?
Cancer Discovery
Oncology
Teaming Up for CAR-T Cell Therapy
Haematologica
Hematology
First-Ever CAR T-Cell Therapy Approved in U.S.
Cancer Discovery
Oncology